Gender-specific assessment of lipid profiles correlation with serum uric acid in non-dialysis chronic kidney disease patients: Prospective observational cross-sectional study
- PMID: 40810061
- PMCID: PMC12343250
- DOI: 10.3389/fendo.2025.1641978
Gender-specific assessment of lipid profiles correlation with serum uric acid in non-dialysis chronic kidney disease patients: Prospective observational cross-sectional study
Abstract
Background: Serum uric acid (SUA) serves as an important marker for assessing kidney function in chronic kidney disease (CKD) patients. Emerging reports suggest a potential relationship between SUA and dyslipidemia. The study aims to examine the correlation between SUA and lipid profiles in CKD population.
Method: We conducted a multicenter, prospective observational cross-sectional study, enrolled n=374 stages 1/4 CKD participants were stratified by gender into (n=210 males and n=164 females). Using a multistage stratified sampling method based on age and SUA to examine the differences among groups, Spearman's correlation and linear regression analysis were utilized to study the association between SUA and lipid profiles, and multivariate analysis to determine the effect of SUA quartiles on multiple dependent variables collectively.
Results: LDL-c was positively correlated with SUA levels, with Spearman's correlation coefficients of R=0.3553 in males and 0.5137 in females (both with P<0.0001). TG also showed a positive correlation, with coefficients R=0.1797 in males and 0.5115 in females (P<0.0091 and P<0.0001, respectively). Similarly, TC showed a positive correlation R=0.2979 in males and 0.2741 in females (P<0.0001 and P<0.0004, respectively), while HDL-c showed an inverse correlation with SUA correlation coefficients R=-0.3445 in males and -0.4055 in females (both with P<0.0001). The age-stratified analysis indicated that LDL-c was higher in individuals aged ≥70 compared to younger groups (P<0.002), while HDL-c was higher in the 20-29 age group; with (P<0.031). Post-hoc univariate tests revealed significant between quartile differences for all lipid variables (all P ≤ 0.05).
Conclusion: In CKD population, SUA levels were positively associated with LDL-c, TC, and TG, while inversely associated with HDL-c. Additionally, lipid profiles were identified as significant predictors of SUA levels. Furthermore, the graded associations of SUA quartiles with lipid profiles suggest that SUA may be employed as a biomarker of dyslipidemia risk among this population.
Keywords: cardiovascular risk; chronic kidney disease; dyslipidemia; hyperuricemia; serum uric acid.
Copyright © 2025 Waheed, Yin, Liu, Almayahe, Bishdary, Munisamy Selvam, Farrukh, Li, Wang, Wang, Zhou and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Associations of serum uric acid trajectories with hypertension risk: exploring differences between age groups.Front Cardiovasc Med. 2025 Jul 4;12:1594142. doi: 10.3389/fcvm.2025.1594142. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40687561 Free PMC article.
-
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2. Cochrane Database Syst Rev. 2024. PMID: 39698949
-
Sex-specific associations between blood urea nitrogen and risk of hyperuricemia in U.S. adults: the NHANES 1999-2020.Front Endocrinol (Lausanne). 2025 Jun 5;16:1560738. doi: 10.3389/fendo.2025.1560738. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40538797 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2025 Jun 27;6:CD006023. doi: 10.1002/14651858.CD006023.pub4. PMID: 30132304 Free PMC article. Updated.
References
-
- Waheed YA, Liu J, Almayahe S, Sun D. The role of hyperuricemia in the progression of end-stage kidney disease and its molecular prospective in inflammation and cardiovascular diseases: A general review. Ther Apheresis Dialysis. (2025). doi: 10.1111/1744-9987.70000. Advance online publication. - DOI - PubMed
-
- Chinese Society of Endocrinology . Guidelines for the diagnosis and management of hyperuricemia and gout in China (2019). Chin J Endocrinol Metab. (2020) 2020:1–13. doi: 10.3760/cma.j.issn.1000-6699.2020.01.001 - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous